Testing effectiveness (Phase 2)Ended earlyNCT05122182
What this trial is testing
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Who this might be right for
COVID-19SARS-CoV2 Infection
University of Sydney 49